https://www.selleckchem.com/products/atn-161.html
We will also test the genotype to determine the relationship between drugs and efficacy. All the data will be recorded in case report forms (CRFs) and analysed by SPSS V.20.0. A randomized clinical trial design to evaluate the efficacy and safety of MBYF in COPD is described. The results will provide evidence for the combination therapy of modern medicine and TCM medicine, and individual therapy for COPD. ID ChiCTR1900026124 , Prospective registration. ID ChiCTR1900026124 , Prospective registration. Cameroon is considering the implement
Like
Comment
Share
